|
SFRS14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.217220E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.333900E-02 |
| Normal-vs-Stage2 |
7.422600E-01 |
| Normal-vs-Stage3 |
2.121800E-03 |
| Normal-vs-Stage4 |
1.849870E-02 |
| Stage1-vs-Stage2 |
4.829600E-01 |
| Stage1-vs-Stage3 |
5.298100E-02 |
| Stage1-vs-Stage4 |
2.251200E-01 |
| Stage2-vs-Stage3 |
1.459160E-01 |
| Stage2-vs-Stage4 |
1.213790E-01 |
| Stage3-vs-Stage4 |
6.851200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.275250E-01 |
| Normal-vs-AfricanAmerican |
1.863820E-01 |
| Normal-vs-Asian |
7.399900E-02 |
| Caucasian-vs-AfricanAmerican |
9.074400E-01 |
| Caucasian-vs-Asian |
2.998600E-01 |
| AfricanAmerican-vs-Asian |
3.826800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.772400E-02 |
| Normal-vs-Female |
6.255000E-01 |
| Male-vs-Female |
1.120600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.094400E-02 |
| Normal-vs-Extreme_Weight |
4.343600E-02 |
| Normal-vs-Obese |
4.606200E-01 |
| Normal-vs-Extreme_Obese |
1.535000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.766800E-01 |
| Normal_Weight-vs-Obese |
1.682850E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.686600E-01 |
| Extreme_Weight-vs-Obese |
1.573650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.609400E-01 |
| Obese-vs-Extreme_Obese |
4.584200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.386800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.201000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.915700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.481900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.910800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.277400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.766000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.138640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.021900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.390760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.567600E-01 |
| Normal-VS-Type2 PRCC |
2.377200E-04 |
| Normal-VS-KIRP CIMP |
2.426200E-02 |
| Normal-VS-Unclassified PRCC |
2.623400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.23819999978225E-07 |
| Type1 PRCC-VS-KIRP CIMP |
6.661800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.039400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.154800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.824000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.124420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.958400E-03 |
| Normal-vs-N1 |
2.291700E-02 |
| Normal-vs-N2 |
8.522500E-02 |
| N0-vs-N1 |
7.721200E-01 |
| N0-vs-N2 |
3.619400E-01 |
| N1-vs-N2 |
4.878400E-01 |
|
|
